NCT04199949

Brief Summary

Physical inactivity is a significant predictor of major non-communicable diseases such as type 2 diabetes (7%), cardiovascular disease (6%), musculoskeletal disorders and some types of cancer, and has been proposed to be the 4th leading cause of death worldwide. The investigators aim is to assess the vascular (endothelial) function before and after a 5-day period of reduced activity of upper and lower limbs via an arm sling and daily step counts reduction, respectively, in healthy participants. Twelve young (ages of 18 - 35 years), healthy, males and females, recreationally active with a body mass index between 18 and 27 kg/m2 will be recruited. The participants will then randomly undergo two 5-day interventions: (A) 5 consecutive days of habitual daily levels of physical activity and matched food intake (Control trial). (B) 5 consecutive days of reduced step count by 80% compared to the Control trial combined with their non-dominant arm placed in a sling and a reduction in food (energy) intake (\~20%) to match the reduction in energy expenditure induced by inactivity (Inactivity trial). On days 1 and 6 of each experimental trial, the endothelial function of the brachial and popliteal arteries, and hand grip strength will be measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

November 19, 2019

Completed
27 days until next milestone

First Posted

Study publicly available on registry

December 16, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

February 23, 2022

Status Verified

February 1, 2022

Enrollment Period

1.3 years

First QC Date

November 19, 2019

Last Update Submit

February 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline of flow-mediated vasodilatation (FMD) of the brachial artery

    The FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes

    Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm

  • Change from baseline of flow-mediated vasodilatation (FMD) of the popliteal artery

    The FMD of the popliteal artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes

    Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm

Secondary Outcomes (1)

  • Hand grip strength

    3 minutes

Study Arms (2)

Control

NO INTERVENTION

5 consecutive days of normal daily levels of physical activity and matched food intake

Inactivity

EXPERIMENTAL

5 consecutive days of reduced step count by 80% compared to the Control trial, whilst placing the non-dominant arm in a sling, and reduced food intake (\~ 20%) to match the reduction in energy expenditure induced by inactivity

Behavioral: Inactivity

Interventions

InactivityBEHAVIORAL

On days 1 and 6 of each main trial, the participants will be asked to attend the laboratory after an overnight fast of at least 8 to 12h to undergo brachial and popliteal arteries FMD measurements (30 min apart) using duplex-Doppler ultrasound, followed by assessment of the hand grip strength of their non-dominant hand using a hand dynamometer.

Inactivity

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non-smoking
  • Males
  • Age (18-35 years old)
  • Body mass index (BMI) of 18-27 kg/m2
  • Recreationally active
  • Ability to give informed consent

You may not qualify if:

  • Smoking
  • Any metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism) or cardiovascular (e.g. heart or blood) abnormalities including hypertension or heart failure
  • Clinically significant abnormalities on screening including ECG abnormalities
  • Taking routine medication that may alter cardiovascular function and blood flow (e.g. blood pressure-lowering drugs or drugs that cause hypertension)
  • Well-trained individuals
  • On an energy-restricted diet or seeking to lose weight
  • High alcohol consumption (\<3-4 units/day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Nottingham

Nottingham, Nottinghamshire, NG7 2RD, United Kingdom

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Moira A Taylor

Study Record Dates

First Submitted

November 19, 2019

First Posted

December 16, 2019

Study Start

November 1, 2018

Primary Completion

March 1, 2020

Study Completion

March 1, 2020

Last Updated

February 23, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations